Skip to main content
SpringerLink
Log in
Book cover

Radiation Therapy for Pelvic Malignancy and its Consequences pp 65–76Cite as

Prevention of Injury from Pelvic Irradiation

  • Chapter
  • First Online:

  • 988 Accesses

Abstract

Radiotherapy is used as a component of therapy for a range of pelvic malignancies and can contribute to substantial toxicity. Preventative strategies including use of different treatment modalities, optimization of treatment technique and planning, and administration of various agents and radioprotectors should be considered to minimize risk of toxicity when possible.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Portelance L, Moughan J, Jhingran A, Miller E, Salehpour MR, D’Souza D, Haddock M, Rotman M, Gaffney DK. A Phase II Multi-institutional Study of Postoperative Pelvic Intensity Modulated Radiation Therapy (IMRT) With Weekly Cisplatin In Patients With Cervical Carcinoma: Two Year Efficacy Results of the RTOG 0418. Proceedings of the 53rd Annual ASTRO Meeting; 2011 Oct 2–6; Miami, USA.

    Google Scholar 

  2. Barillot I, Tavernier E, Peignaux K, Willaume D, Nickers P, Leblanc-Onfroy M, et al. Impact of post-operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: results of the phase II RTCMIENDOMETRE French multicenter trial. Radiother Oncol. 2014;111(1):138–43.

    Article  PubMed  Google Scholar 

  3. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, Roeske JC. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Bio Phys. 2002;52(2):1330–7.

    Article  Google Scholar 

  4. Mundt AJ, Mell MK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 2003;56(5):1354–60.

    Article  PubMed  Google Scholar 

  5. Garofalo M, Moughan J, Hong T, Bendell J, Berger A, Lerma F, Lee R, Anne P, Sharma N, Crane C. RTOG 0822: A Phase II Study of Preoperative Chemoradiotherapy (CRT) Utilizing IMRT in Combination with Capcitabine (C) and Oxaliplatin (O) for Patients with Locally Advanced Rectal Cancer. Proceedings of the 53rd Annual ASTRO Meeting; 2011 Oct 2–6; Miami, USA

    Google Scholar 

  6. Samuelian JM, Callister MD, Ashman JB, Young-Fadok TM, Borad MJ, Gunderson LL. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2012;82(5):1981–7.

    Article  PubMed  Google Scholar 

  7. Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, Haddock MG, Rotman M, Parikh PJ, Safran H, Willett CG. RTOG 0529: a phase II evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluoruracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013;86(1):27–33.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Chuong MD, Freilich JM, Hoffe SE, Fulp W, Weber JM, Almhanna K, et al. Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal. Gastrointest Cancer Res. 2013;6(2):39–45.

    PubMed Central  PubMed  Google Scholar 

  9. Alicikus ZA, Yamada Y, Zhang Z, Pei X, Hunt M, Kollmeier M, et al. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 2011;117(7):1429–37.

    Article  PubMed  Google Scholar 

  10. Forsythe K, Blacksburg S, Stone N, Stock RG. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83(2):630–5.

    Article  PubMed  Google Scholar 

  11. Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(4):1124–9.

    Article  PubMed  Google Scholar 

  12. Alongi F, Fiorino C, Cozzarini C, Broggi S, Perna L, Cattaneo GM, et al. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol. 2009;93(2):207–12.

    Article  PubMed  Google Scholar 

  13. Longobardi B, Berardi G, Fiorino C, Alongi F, Cozzarini C, Deli A, et al. Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with tomotherapy. Radiother Oncol. 2011;101(3):460–4.

    Article  PubMed  Google Scholar 

  14. Gray PJ, Paly JJ, Yeap BY, Sandra MG, Sandler HM, Michalski JM, et al. Patient-reported outcomes after 3-dimensional conformal, intensity-modulated or proton beam radiotherapy for localized prostate cancer. Cancer. 2013;119(9):1729–35.

    Article  PubMed  Google Scholar 

  15. Sheets NC, Goldin GH, Meyer AM, Wu Y, Chang Y, Stürmer T, Holmes JA, Reeve BB, Godley PA, Carpenter WR, Chen RC. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA. 2012; 307(15):1611–20.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Ohri N, Dicker AP, Showalter TN. Late toxicity rates following definitive radiotherapy for prostate cancer. Can J Urol. 2012;19(4):6373–80.

    PubMed Central  PubMed  Google Scholar 

  17. Drzymala M, Hawkins MA, Henrys AJ, Bedford J, Norman A, Tait DM. The effect of treatment position, prone or supine, on dose-volume histograms for pelvic radiotherapy in patients with rectal cancer. Br J Radiol. 2009;82(976):321–7.

    Article  CAS  PubMed  Google Scholar 

  18. Koebl O, Richter S, Flentje M. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys. 1999;176(3):105–11.

    Google Scholar 

  19. Ghosh K, Padilla LA, Murray KP, Downs LS, Carson LF, Dusenbery KE. Using a belly board to reduce the small bowel volume within the pelvic radiation fields in women with postoperatively treated cervical carcinoma. Gynecol Oncol. 2001;83(2):271–5.

    Article  CAS  PubMed  Google Scholar 

  20. Jain S, Loblaw DA, Morton GC, Danjoux C, Szumacher E, Chu W, et al. The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer. Radiother Oncol. 2012;105(2):193–7.

    Article  PubMed  Google Scholar 

  21. Mahantshetty U, Krishnatry R, Chaudhari S, Kanaujia A, Engineer R, Chopra S, et al. Comparison of 2 contouring methods of bone marrow on CT and correlation with hematological toxicities in non-bone marrow-sparing pelvic intensity-modulated radiotherapy with concurrent cisplatin for cervical cancer. Int J Gynecol Cancer. 2012;22(8):1427–34.

    Article  PubMed  Google Scholar 

  22. de Jong RA, Pras E, Boezen HM, van der Zee AG, Mourits MJ, Arts HJ, et al. Less gastrointestinal toxicity after adjuvant radiotherapy on a small pelvic field compared to a standard pelvic field in patients with endometrial carcinoma. Int J Gynecol Cancer. 2012;22(7):1177–86.

    Article  PubMed  Google Scholar 

  23. Roach M 3rd, DeSilvio M, Valicenti R, Brignon D, Asbell SO, Lawton C, et al. Whole-pelvis, “mini-pelvis,” or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys. 2006;66(3):647–53.

    Article  PubMed  Google Scholar 

  24. Vordermark D, Schwab M, Ness-Dourdoumas R, Sailer M, Flentje M, Koelbl O. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol. 2003;69(2):209–14.

    Article  PubMed  Google Scholar 

  25. Klopp AH, Moughan J, Portelance L, Miller BE, Salehpour MR, Hildebrandt E, et al. Hematolgic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys. 2013;86(1):83–90.

    Article  CAS  PubMed  Google Scholar 

  26. Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, et al. Association between bone marrow dosimetric parameters and acute hematolgic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70(5):141–7.

    Article  Google Scholar 

  27. Fiorino C, Rancati T, Valdagni R. Predictive models of toxicity in external radiotherapy: dosimetric issues. Cancer 2009;115(Supp 13):3135–40.

    Article  PubMed  Google Scholar 

  28. Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Int J Radiat Oncol Biol Phys. 2012;82(1):235–41.

    Article  PubMed  Google Scholar 

  29. Smeenk RJ, Hoffman AL, Hopman WP, van Lin EN, Kaanders JH, et al. Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(2):636–44.

    Article  PubMed  Google Scholar 

  30. Chopra S, Dora T, Chinnachamy AN, Thomas B, Kannan S, Engineer R, et al. Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study. Int J Radiat Oncol Biol Phys. 2014;88(3):630–5.

    Article  PubMed  Google Scholar 

  31. Monroe AT, Pikaart D, Peddeda AV. Clinical outcomes of image guided radiation therapy (IGRT) with gold fiducial vaginal cuff markers for high-risk endometrial cancer. Acta Oncol. 2013;52(2):1010–6.

    Article  PubMed  Google Scholar 

  32. Kok D, Gill S, Bressel M, Byrne K, Kron T, Fox C, et al. Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image-guided radiotherapy. Radiother Oncol. 2013;107(2):140–146.

    Article  PubMed  Google Scholar 

  33. Zelefsky MJ, Kollmeier M, Cox B, Fidaleo A, Sperling D, Pei X, et al. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;84(1):125–9.

    Article  PubMed  Google Scholar 

  34. Gondi V, Bentzen SM, Sklenar KL, Dunn EF, Petereit DG, Tannehill SP, et al. Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis. Int J Radiat Oncol Biol Phys. 2012;84(4):973–82.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Johnson N, Miles TP, Cornes P. Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. BJOG 2010;117(5):522–31.

    Article  CAS  PubMed  Google Scholar 

  36. Small W, James J, Moore T, Fintel D, Lutz S, Movsas B, Suntharalingam M, Graces Y, Ivker R, Berk L. A phase II randomized trial with Captopril in patients who have received radiation therapy + /- chemotherapy for stage II-IIIB non-small cell lung cancer and stage I central non-small cell lung cancer, or limited-stage small-cell lung cancer: RTOG 0123. Proceedings of the 51st Annual ASTRO Meeting; 2009 Nov 1–5; Chicago, USA

    Google Scholar 

  37. Wedlake LJ, Silia F, Benton B, Lalji A, Thomas K, Dearnaley DP, et al. Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies. Eur J Cancer. 2012;48(14):2117–24.

    Article  CAS  PubMed  Google Scholar 

  38. Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V, et al. Randomized controlled trial of live lactobacillus acidophilus plus bififobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol. 2010;5:31.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Giralt J, Regadera JP, Verges R, Romero J, de la Fuente I, Biete A, et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys. 2008;71(4):1213–9.

    Article  PubMed  Google Scholar 

  40. Wedlake LJ, McGough C, Shaw C, Klopper T, Thomas K, Lalji A, et al. Clinical trial: efficacy of a low or modified fat diet for the prevention of gastrointestinal toxicity in patients receiving radiotherapy treatment for pelvic malignancies. J Hum Nutr Diet. 2012;25(3):247–59.

    Article  CAS  PubMed  Google Scholar 

  41. Wedlake LJ, Shaw C, Whelan K, et al, Andreyev HJ. Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy. Aliment Pharmocol Ther. 2013;37(11):1046–56.

    Article  CAS  Google Scholar 

  42. Kilic D, Egehan I, Ozenirler S, Dursen A. Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother Oncol. 2000;57(2):125–9.

    Article  CAS  PubMed  Google Scholar 

  43. Zimmerer T, Böcker U, Wenz F, Singer MV. Medical prevention and treatment of acute and chronic radiation induced enteritis—is there any proven therapy? A short review. Z Gastroenterol. 2008;46(5):441–8.

    Article  CAS  PubMed  Google Scholar 

  44. Kouloulias VE, Kouvaris JR, Pissakas G, Kokakis JD, Antypas C, Mallas E, et al. A phase II randomized study of topical intrarectal administration of amifostine for the prevention of acute radiation-induced rectal toxicity. Strahlenther Onkol. 2004;180(9):567–62.

    Article  Google Scholar 

  45. Small W Jr., Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II or Radiation Therapy Oncology Group (RTOG) 0116. Int J Gynecol Cancer. 2011;21(7):1266–75.

    PubMed  Google Scholar 

  46. Esco R, Valencia J, Coronel P, Caraceller JA, Gimeno M, Bascón N. Efficacy of orgotein in prevention of late side effects of pelvic irradiation: a randomized study. Int J Radiat Oncol Biol Phys. 2004;60(4):1211–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Northwestern Memorial Hospital, Chicago, IL, USA

    Prof. Michelle S. Gentile MD, PhD

  2. Department of Radiation Oncology, Stritch School of Medicine Loyola University Chicago, Cardinal Bernardin Cancer Center, Gynecologic Cancer InterGroup (GCIG): Chair-Elect, 2160 S 1st Ave, Maguire Center, Rm 2932, Maywood, 60153, IL, USA

    William Small Jr. MD, FACRO, FACR, FASTRO

Authors
  1. Prof. Michelle S. Gentile MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William Small Jr. MD, FACRO, FACR, FASTRO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michelle S. Gentile MD, PhD .

Editor information

Editors and Affiliations

  1. University of Chicago Medical School, NorthShore University Health System, Highland Park, Illinois, USA

    Eli Daniel Ehrenpreis

  2. University of Chicago Pritzker School of Medicine, NorthShore University Health System, Highland Park, Illinois, USA

    R de W Marsh

  3. Department of Radiation Oncology, Stritch School of Medicine, Loyola University, Chicago, Illinois, USA

    William Small Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gentile, M., Small, W. (2015). Prevention of Injury from Pelvic Irradiation. In: Ehrenpreis, E., Marsh, R., Small Jr., W. (eds) Radiation Therapy for Pelvic Malignancy and its Consequences. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2217-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2217-8_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2216-1

  • Online ISBN: 978-1-4939-2217-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation